No Prescription |
 |
 | ||
|
TEROL Torq |
|
| ||
No Prescription » Prescription Drugs 16 » TEROL Torq Tolterodine is used to relieve urinary difficulties including frequent urination and inability to control urination. Tolterodine is in a class of medications called antimuscarinics. It works by preventing bladder contraction.How to use Tolterodine OralTake this medication by mouth with or without food usually twice a day or as directed by your doctor.Use this medication regularly in order to get the most benefit from it. Remember to use it at the same times each day. Dosage is based on your medical condition (especially kidney and liver disease) response to therapy and use of certain interacting medicines. Consult your doctor or pharmacist for more details.Do not increase your dose or take this medication more often without your doctor's approval. Your condition will not improve any faster and the risk of serious side effects may be increased.Inform your doctor if your condition does not improve or if it worsens. Buy TEROL Torq and other Prescription Drugs 16 products online at Medstore. 972
About TEROL Torq: Product Type: Prescription Drugs 16 TEROL ( Torq Detrol Generic Tolterodine ) TEROL (Torq Detrol Generic Tolterodine) Torq Detrol Generic Tolterodine 2 mg Tab 30 (3 x 10) Torq Detrol Generic Tolterodine TEROL
View more Prescription Drugs 16 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
